Jeff Yass’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-141,809
| Closed | -$12.9M | – | 10905 |
|
|
2018
Q1 | $11.2M | Sell |
141,809
-114,130
| -45% | -$8.42M | ﹤0.01% | 1678 |
|
|
2017
Q4 | $17.5M | Buy |
+255,939
| New | +$13.3M | 0.01% | 1353 |
|
|
2017
Q3 | – | Sell |
-92,552
| Closed | -$3.57M | – | 10121 |
|
|
2017
Q2 | $3.68M | Buy |
+92,552
| New | +$3.39M | ﹤0.01% | 2827 |
|
|
2017
Q1 | – | Sell |
-239,057
| Closed | -$5.96M | – | 10617 |
|
|
2016
Q4 | $4.23M | Buy |
239,057
+114,425
| +92% | +$2.47M | ﹤0.01% | 2692 |
|
|
2016
Q3 | $2.91M | Buy |
124,632
+83,049
| +200% | +$1.89M | ﹤0.01% | 2950 |
|
|
2016
Q2 | $776K | Sell |
41,583
-46,329
| -53% | -$837K | ﹤0.01% | 5356 |
|
|
2016
Q1 | $1.6M | Buy |
87,912
+38,231
| +77% | +$616K | ﹤0.01% | 4197 |
|
|
2015
Q4 | $1.05M | Sell |
49,681
-86,414
| -63% | -$1.67M | ﹤0.01% | 5317 |
|
|
2015
Q3 | $2.51M | Sell |
136,095
-28,157
| -17% | -$703K | ﹤0.01% | 3842 |
|
|
2015
Q2 | $5.56M | Sell |
164,252
-347,642
| -68% | -$14M | ﹤0.01% | 2748 |
|
|
2015
Q1 | $24.6M | Buy |
511,894
+391,727
| +326% | +$17.8M | 0.01% | 1080 |
|
|
2014
Q4 | $2.67M | Buy |
120,167
+77,546
| +182% | +$1.79M | ﹤0.01% | 3929 |
|
|
2014
Q3 | $808K | Buy |
42,621
+868
| +2% | +$20.7K | ﹤0.01% | 6348 |
|
|
2014
Q2 | $1.13M | Buy |
41,753
+31,007
| +289% | +$786K | ﹤0.01% | 5792 |
|
|
2014
Q1 | $348K | Buy |
+10,746
| New | +$349K | ﹤0.01% | 7361 |
|
Jeff Yass's FMI Position: Q2 2018 in Review
Jeff Yass sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 141,809 shares — an estimated $12.9M sold.
Jeff Yass first reported a position in FMI in Q1 2014 and held it in 15 quarters. The position peaked at $24.6M in Q1 2015. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.
- Jeff Yass reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
- Jeff Yass sold 141,809 Foundation Medicine, Inc. shares in Q2 2018, an estimated $12.9M.
- Jeff Yass first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 15 quarters.
- Jeff Yass's Foundation Medicine, Inc. position peaked at $24.6M in Q1 2015.
- 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.